Felicity (Flic) Gabbay, BSc FFPM FRCP

Senior Partner

Email: flic.gabbay@transcrip-partners.com

Flic is a pharmaceutical physician with over 25 years of industry experience, including as Global Head of Anti-infectives, at Parke Davis in the US. She has worked for pharma and bio-tech companies in Europe and North America on a range of projects including monoclonals, transgenics, respiratory, anti-inflammatories, lipid lowering agents, anti-infectives and oncology.

Flic is Non-executive Chairman of Phico Therapeutics, a novel antibiotic development company and has recently retired from the Board of Directors of Bioanalab after its successful acquisition.

In 1990, Flic founded Gabbay Group, a CRO acquired by PPD where she was Global VP for Regulatory and Clinical Research. She has also been CEO of two small biotech companies, Director of Education at the Drug Safety Research Unit in Southampton and founder Chairman of the Society of Pharmaceutical Medicine.

Flic was Chairman of the steering group that set-up the UK Faculty of Pharmaceutical Medicine and, for nine years, its Academic Registrar. She is a current member of the FPM Board of Examiners. She has been an active member of expert international working parties on research programme regulatory guidelines for anti-infectives, respiratory drugs, rheumatology and headache. Flic is a Fellow of the Faculty of Pharmaceutical Medicine, and of the Royal College of Physicians.